MedTrace Logo

Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals

NCT06229899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2024-01-30

No results posted yet for this study

Summary

There is no clear boundary on which obese individuals should be considered metabolically healthy and which should be considered metabolically unhealthy. It is also not very clear whether the individuals who are considered metabolically healthy will remain healthy in the future. The objective of this study was to assess potential disparities in serum follistatin levels between these two distinct groups. Furthermore, the study sought to investigate whether this disparity could serve as a reliable indicator for distinguishing between metabolically healthy and unhealthy obese individuals.

Conditions

Interventions

DIAGNOSTIC_TEST

Serum follistatin levels

blood samples are taken

Sponsors & Collaborators

  • Goztepe Prof Dr Suleyman Yalcın City Hospital

    lead OTHER

Principal Investigators

  • Ayşe N Erbakan, MD · Istanbul Medeniyet University Goztepe Research and TRaining Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-15
Primary Completion
2023-01-15
Completion
2023-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229899 on ClinicalTrials.gov